A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1

Journal of Virological Methods

Volumn 159, Issue 1, 2009, Pages 112-118

  Ko, Young Joon ^a   Jeoung, Hye Young ^a   Lee, Hyang Sim ^a   Chang, Byung Sik ^b   Hong, Seung Min ^a   Heo, Eun Jeong ^a   Lee, Kwang Nyeong ^a   Joo, Hoo Don ^b   Kim, Su Mi ^a   Park, Jong Hyeon ^a   Kweon, Chang Hee ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Jenobiotech Inc   (South Korea)

Author keywords

ELISA; Foot and mouth disease virus; Recombinant protein; Serology; Serotype Asia 1

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEINASE; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; CONTROLLED STUDY; COW; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FOOT AND MOUTH DISEASE VIRUS; GOAT; INSECT CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM; SWINE; VACCINATION; VIRUS NEUTRALIZATION; VIRUS TITRATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CAPSID PROTEINS; CATTLE; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GOATS; MICE; NEUTRALIZATION TESTS; RABBITS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPODOPTERA; SWINE; VIRAL PROTEINS;

BOVINAE; CAPRA; CAPRA HIRCUS; FOOT-AND-MOUTH DISEASE VIRUS; HEXAPODA; SUIDAE;

EID: 67349131914     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.03.011     Document Type: Article

References (37)

1. Abrams C.C., King A.M.Q., and Belsham G.J. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 76 (1995) 3089-3098
2. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., and Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337 (1989) 709-716
3. Barnett P.V., Statham R.J., Vosloo W., and Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21 (2003) 3240-3248
4. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., and Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
5. Brautigam S., Snezhkov E., and Bishop D.H. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Virology 192 (1993) 512-524
6. Chenard G., Miedema K., Moonen P., Schrijver R.S., and Dekker A. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J. Virol. Methods 107 (2003) 89-98
7. Cooke J.N., and Westover K.M. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis. Infect. Genet. Evol. 8 (2008) 855-863
8. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., and Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232 (1986) 639-641
9. Domingo E., Escarm C., Baranowski E., Ruiz-Jarabo C.M., Carrillo E., Nunez J.I., and Sobrino F. Evolution of foot-and-mouth disease virus. Virus Res. 91 (2003) 47-63
10. Goris N., Maradei E., D'Aloia R., Fondevila N., Mattion N., Perez A., Smitsaart E., Nauwynck H.J., La Torre J., Palma E., and De Clercq K. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test. Vaccine 26 (2008) 3432-3437
11. Grubman M.J., and Baxt B. Foot-and-mouth disease. Clin. Microbiol. Rev. 17 (2004) 465-493
12. Haas, B., 1994. Application of the FMD liquid-phase blocking sandwich ELISA. Problems encountered in import/export serology and possible solutions, September 19-22, Vienna, pp. 124-127.
13. Hamblin C., Barnett I.T., and Hedger R.S. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J. Immunol. Methods 93 (1986) 115-121
14. Hu Y.-C., Hsu J.T.-A., Huang J.-H., Ho M.-S., and Ho Y.-C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol. Lett. 25 (2003) 919-925
15. Kitching P., Hammond J., Jeggo M., Charleston B., Paton D., Rodriguez L., and Heckert R. Global FMD control-is it an option?. Vaccine 25 (2007) 5660-5664
16. Knowles N.J., and Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 91 (2003) 65-80
17. Lee K.N., Oem J.K., Park J.H., Kim S.M., Lee S.Y., Tserendorj S., Sodnomdarjaa R., Joo Y.S., and Kim H. Evidence of recombination in a new isolate of foot-and-mouth disease virus serotype Asia 1. Virus Res. 139 (2009) 117-121
18. Lewis S.A., Morgan D.O., and Grubman M.J. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65 (1991) 6572-6580
19. Mackay D.K.J., Bulut A.N., Rendle T., Davidson F., and Ferris N.P. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J. Virol. Methods 97 (2001) 33-48
20. Mason P.W., Grubman M.J., and Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 91 (2003) 9-32
21. Niedbalski W. Comparison of different ELISA methods for the detection of antibodies against foot-and-mouth disease virus (FMDV) type O. Bull. Vet. Inst. Pulawy 48 (2004) 5-9
22. Oem J.K., Park J.H., Lee K.N., Kim Y.J., Kye S.J., Park J.Y., and Song H.J. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine 25 (2007) 4112-4121
23. OIE. Foot-and-mouth disease. OIE, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (mammals, birds and bees) (2008), OIE, Paris, France pp. 198-199
24. Paiba G.A., Anderson J., Paton D.J., Soldan A.W., Alexandersen S., Corteyn M., Wilsden G., Hamblin P., MacKay D.K.J., and Donaldson A.I. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). J. Virol. Methods 115 (2004) 145-158
25. Pay T.W., and Hingley P.J. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine 10 (1992) 699-706
26. Pfaff E., Mussgay M., Bohm H.O., Schulz G.E., and Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1 (1982) 869-874
27. Robiolo B., Grigera P.R., Periolo O.H., Seki C., Bianchi T., Maradei E., and La Torre J.L. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13 (1995) 1346-1352
28. Rodriguez L.L., Barrera J., Kramer E., Lubroth J., Brown F., and Golde W.T. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21 (2003) 3751-3756
29. Roosien J., Belsham G.J., Ryan M.D., King A.M.Q., and Vlak J.M. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 71 (1990) 1703-1711
30. Rweyemamu M., Roeder P., Mackay D., Sumption K., Brownlie J., Leforban Y., Valarcher J.F., Knowles N.J., and Saraiva V. Epidemiological patterns of foot-and-mouth disease worldwide. Transbound. Emerg. Dis. 55 (2008) 57-72
31. Strohmaier K., Franze R., and Adam K.H. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59 (1982) 295-306
32. Sugiyama M., Yoshiki R., Tatsuno Y., Hiraga S., Itoh O., Gamoh K., and Minamoto N. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs. Clin. Diagn. Lab. Immunol. 4 (1997) 727-730
33. Valarcher J.F., Knowles N.J., Ferris N.P., Paton D.J., Zakharov V., Sherbakov A., Shang Y.J., Liu Z.X., Liu X.T., Sanyal A., Hemadri D., Tosh C., and Rasool T.J. Recent spread of FMD virus serotype Asia 1. Vet. Rec. 157 (2005) 30
34. Valarcher J.F., Leforban Y., Rweyemamu M., Roeder P.L., Gerbier G., Mackay D.K., Sumption K.J., Paton D.J., and Knowles N.J. Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transbound. Emerg. Dis. 55 (2008) 14-34
35. Van Maanen C., and Terpstra C. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J. Immunol. Methods 124 (1989) 111-119
36. Wang C.Y., Chang T.Y., Walfield A.M., Ye J., Shen M., Chen S.P., Li M.C., Lin Y.L., Jong M.H., Yang P.C., Chyr N., Kramer E., and Brown F. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20 (2002) 2603-2610
37. Ypma-Wong M.F., Dewalt P.G., Johnson V.H., Lamb J.G., and Semler B.L. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166 (1988) 265-270